Wellington Management Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Wellington Management Group’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,259	Closed	-$363K	–	2292
2021 Q2	$363K	Sell	8,259 -549	-6%	-$30.6K	﹤0.01%	1986
2021 Q1	$639K	Sell	8,808 -40,288	-82%	-$2.86M	﹤0.01%	1804
2020 Q4	$2.12M	Sell	49,096 -115,990	-70%	-$5.19M	﹤0.01%	1485
2020 Q3	$6.79M	Sell	165,086 -50,939	-24%	-$2.63M	﹤0.01%	1200
2020 Q2	$13M	Sell	216,025 -20,852	-9%	-$1.91M	﹤0.01%	1017
2020 Q1	$17.8M	Sell	236,877 -85,029	-26%	-$9.79M	﹤0.01%	904
2019 Q4	$44.3M	Buy	321,906 +227,910	+242%	+$27.7M	0.01%	786
2019 Q3	$11.2M	Buy	93,996 +7,696	+9%	+$1.07M	﹤0.01%	1129
2019 Q2	$12.1M	Buy	+86,300	New	+$15.2M	﹤0.01%	1152

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Wellington Management Group's ORTX Position: Q3 2021 in Review

Wellington Management Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 8,259 shares — an estimated $363K sold.

Wellington Management Group first reported a position in ORTX in Q2 2019 and held it in 9 quarters. The position peaked at $44.3M in Q4 2019. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Wellington Management Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Wellington Management Group sold 8,259 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $363K.
Wellington Management Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 9 quarters.
Wellington Management Group's Orchard Therapeutics plc American Depositary Shares position peaked at $44.3M in Q4 2019.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Wellington Management Group's 13F filing for Q3 2021, filed 15 Nov 2021.